Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-28

Clinical Trial Update: Efficacy and Safety of Human Urinary Kallidinogenase for Acute Ischemic Stroke Patients Receiving Reperfusion Treatment [NA]

View source ↗

Summary

This clinical trial update notes ongoing recruitment for a study evaluating the efficacy and safety of human urinary kallidinogenase in acute ischemic stroke pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Human Urinary Kallidinogenase (kallidinogenase)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Acute Ischemic Stroke | NA | Status: RECRUITING